Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Signal recognition particle 19 kDa protein (SRP19) is a highly conserved accessory protein component of the eukaryotic and archaeal signal recognition particle (SRP), a ribonucleoprotein complex fundamental for co-translational targeting of proteins to membranes[1][2][3]. SRP19 serves a crucial structural and assembly function by binding specifically to helix 6 of SRP RNA, promoting the correct folding and juxtaposition of SRP helices 6 and 8, which is a prerequisite for subsequent binding of SRP54 and maturation of a functional SRP complex[1][2][3]. SRP19 acts as a molecular scaffold and RNA-binding chaperone, but does not participate in direct recognition of signal sequences or catalysis; it is not classified as a drug target, receptor, enzyme, transporter, or transcription factor[1][2][3]. There are currently no known disease associations, interacting drugs, or biomarker or safety concerns linked to SRP19.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Signal recognition particle 19 kDa protein (SRP19).